tiprankstipranks
Molecular Partners (MOLN)
NASDAQ:MOLN
US Market
MOLN
Molecular Partners
RESEARCH TOOLSreports
Want to see MOLN full AI Analyst Report?

Molecular Partners (MOLN) Stock News & Sentiment

59 Followers
Molecular Partners: Pipeline Momentum and Early Safety Data Support Unchanged $12 Price Target and Buy Rating
Premium
Ratings
Molecular Partners: Pipeline Momentum and Early Safety Data Support Unchanged $12 Price Target and Buy Rating
19d ago
MOLN
Molecular Partners Advances DLL3 Radio-DARPin MP0712 and Expands Alpha Therapy Pipeline on Solid H1 2026 Cash Base
Premium
Company Announcements
Molecular Partners Advances DLL3 Radio-DARPin MP0712 and Expands Alpha Therapy Pipeline on Solid H1 2026 Cash Base
20d ago
6K
MOLN
Molecular Partners Starts Phase 2 TACTIC Trial of MP0317 in Front-Line Cholangiocarcinoma
Premium
Company Announcements
Molecular Partners Starts Phase 2 TACTIC Trial of MP0317 in Front-Line Cholangiocarcinoma
2M ago
6K
MOLN
Molecular Partners Advances Radio-DARPin Cancer Pipeline With MP0712 Trial and Upcoming MP0726 Imaging
Premium
Company Announcements
Molecular Partners Advances Radio-DARPin Cancer Pipeline With MP0712 Trial and Upcoming MP0726 Imaging
2M ago
6K
MOLN
Molecular Partners Reaffirmed at Buy as Analyst Cites MP0712 Progress and Keeps $12 Price Target Unchanged
Premium
Ratings
Molecular Partners Reaffirmed at Buy as Analyst Cites MP0712 Progress and Keeps $12 Price Target Unchanged
2M ago
MOLN
Molecular Partners and Orano Med Dose First Patients in MP0712 Phase 1/2a Trial
Premium
Company Announcements
Molecular Partners and Orano Med Dose First Patients in MP0712 Phase 1/2a Trial
2M ago
6K
MOLN
Molecular Partners Starts Dosing DLL3 Radio-DARPin MP0712, Highlights Program at ASCO and SNMMI 2026
Premium
Company Announcements
Molecular Partners Starts Dosing DLL3 Radio-DARPin MP0712, Highlights Program at ASCO and SNMMI 2026
3M ago
6K
MOLN
More MOLN News >

MOLN News on the Web

Clear Street transfers coverage on Molecular Partners, keeps Buy rating
TipRanks News
Bullish
Molecular Partners To Advance MP0726 For First Human Imaging In H2,2026; Provides MP0712 Update
rttnews
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (ALNY), Molecular Partners (MOLN) and Exelixis (EXEL)
TipRanks News
Bullish
Molecular Partners and Orano Med Dose First Patients in MP0712 Phase 1/2a Trial
TipRanks News
Neutral
Molecular Partners, Orano Med doses first patient in MP0712 study
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Disc Medicine (IRON), Molecular Partners (MOLN) and Park Dental Partners, Inc. (PARK)
TipRanks News
Bullish
Molecular Partners to hold trial-in-progress presentations on Phase 1/2a study
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MOLN’s Media Buzz Sentiment?
Currently, no data Available
What is MOLN’s weekly average amount of articles?
In an average week, 0.75 articles about MOLN are published.
    What is MOLN’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    ABBVAbbVie
    IRDOpus Genetics
    TMDXTransMedics Group
    BMYBristol-Myers Squibb
    IDYAIDEAYA Biosciences
    Showing the stocks with the most bullish news sentiment over the past week